Heiko Konig

  • 803 Citations
  • 14 h-Index
20032019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Heiko Konig is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Leukemia, Myelogenous, Chronic, BCR-ABL Positive Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Protein-Tyrosine Kinases Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
src-Family Kinases Medicine & Life Sciences
Cytogenetics Medicine & Life Sciences
Phosphotransferases Medicine & Life Sciences
Interferons Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Publications 2003 2019

  • 803 Citations
  • 14 h-Index
  • 17 Article
  • 6 Review article
  • 1 Letter
1 Citation (Scopus)

Combination of sorafenib, vorinostat and bortezomib for the treatment of poor-risk AML: report of two consecutive clinical trials

Sayar, H., Cripe, L., Saliba, A. N., Abu Zaid, M., Konig, H. & Boswell, H., Feb 1 2019, In : Leukemia Research. 77, p. 30-33 4 p.

Research output: Contribution to journalLetter

Acute Myeloid Leukemia
Clinical Trials
vorinostat
sorafenib
Bortezomib
1 Citation (Scopus)

Consecutive epigenetically-active agent combinations act in ID1-RUNX3-TET2 and HOXA pathways for Flt3ITD+ve AML

Sayar, H., Liu, Y., Gao, R., Zaid, M. A., Cripe, L., Weisenbach, J., Sargent, K. J., Nassiri, M., Li, L., Konig, H., Suvannasankha, A., Pan, F., Shanmugam, R., Goswami, C., Kapur, R., Xu, M. & Scott Boswell, H., Jan 1 2018, In : Oncotarget. 9, 5, p. 5703-5715 13 p.

Research output: Contribution to journalArticle

Wnt Signaling Pathway
Mutation
Epigenetic Repression
Histone Deacetylase Inhibitors
Chromatin Assembly and Disassembly
8 Citations (Scopus)

The rocky road to personalized medicine in acute myeloid leukaemia

Brinda, B., Khan, I., Parkin, B. & Konig, H., Mar 1 2018, In : Journal of Cellular and Molecular Medicine. 22, 3, p. 1411-1427 17 p.

Research output: Contribution to journalReview article

Precision Medicine
Acute Myeloid Leukemia
Consolidation Chemotherapy
Induction Chemotherapy
Poisons
49 Citations (Scopus)

A randomized assessment of adding the kinase inhibitor lestaurtinib to first-line chemotherapy for FLT3-mutated AML

Knapper, S., Russell, N., Gilkes, A., Hills, R. K., Gale, R. E., Cavenagh, J. D., Jones, G., Kjeldsen, L., Grunwald, M. R., Thomas, I., Konig, H., Levis, M. J. & Burnett, A. K., Mar 2 2017, In : Blood. 129, 9, p. 1143-1154 12 p.

Research output: Contribution to journalArticle

Chemotherapy
Acute Myeloid Leukemia
Protein-Tyrosine Kinases
Phosphotransferases
Drug Therapy
5 Citations (Scopus)

Enzyme-immobilized hydrogels to create hypoxia for in vitro cancer cell culture

Dawes, C. S., Konig, H. & Lin, C. C., Apr 20 2017, In : Journal of Biotechnology. 248, p. 25-34 10 p.

Research output: Contribution to journalArticle

Immobilized Enzymes
Glucose Oxidase
Glucose oxidase
Hydrogels
Cell culture